Our laboratory is interested in different aspects of the molecular and cellular basis underlying the pathology of malaria. The deadliest of the human malaria parasites, Plasmodium falciparum, causes several hundred million infections and 1-2 million deaths each year. The clinical symptoms of malaria are a result of the parasite undergoing repeated cycles of invasion into red blood cells and intracellular reproduction.
P. falciparum erythrocyte membrane protein 1 (PfEMP) is localized on the infected red blood cell (RBC) surface. PfEMP1 is encoded by the var multigene family and it represents a major parasite virulence factor due to its central role in parasite sequestration and immune evasion. There is increasing evidence that the differential binding properties of PfEMP1 variants to specific host receptors are directly linked to the cytoadherence of infected RBC (iRBC) to the microvascular endothelium. We are using transgenic parasite lines expressing PfEMP1 virulence domains to gain a better understanding of the link between the expression of PfEMP1 and pathology.
During the cycle in human red blood cells, the parasite induces drastic morphological changes of its host cell. This mechanism of host cell remodeling serves to induce cytoadherence of iRBCs to host vascular endothelium, to facilitate nutrient import and immune evasion. The recent identification of a conserved motif required for export of virulence and remodeling factors from the parasite to the host allowed a classification of the exportome in P.falciparum and other Plasmodium species. A comparative functional analysis of exported proteins in different Plasmodium species allows us to investigate the evolution of virulence in malaria parasites on a molecular and cellular level.